BioSpace News Archive

BioCapital

RegeneRx Biopharmaceuticals, Inc. Release: Dr. Michael Chopp Reports On Successful Remodeling Of The Central And Peripheral Nervous Systems After Injury/Disease Using Thymosin Beta 4

October 23, 2014
·
3 min read
Business

Alkermes plc To Host Conference Call To Discuss Third Quarter 2014 Financial Results

October 23, 2014
·
1 min read
Business

Alexion Pharmaceuticals Inc. Reports Third Quarter 2014 Results

October 23, 2014
·
1 min read
Rock Creek Pharmaceuticals Announces Presentation Of Four Anatabine Projects At Neuroscience 2014

October 23, 2014
·
5 min read
Drug Development

Vaxart, Inc. Accelerates Development Of Ebola Tablet Vaccine

October 23, 2014
·
3 min read
Genetown

Epizyme Announces Notices Of Allowance For US Patent Applications Covering PRMT5 Inhibitors And Methods Of Cancer Treatment With PRMT5 Inhibitors

October 23, 2014
·
1 min read
BioCapital

Castle Biosciences’ Multi-Analyte Test Successfully Identifies Esophageal Cancer Patients Who Are Extremely Resistant To Standard Treatment Of Chemoradiation Therapy

October 23, 2014
·
1 min read
Biotech Beach

Flint Rehabilitation Devices Introduces MusicGlove, World’s First FDA Approved, Clinically Validated Music-Based Hand Rehabilitation Device

October 23, 2014
·
1 min read
Drug Development

Cellceutix Announces Positive Top-Line Data From Phase 2b ABSSSI Trial; Single-Dose Brilacidin Comparable To 7-Days Of Daptomycin

October 23, 2014
·
5 min read
Data Presented At The International Society Of Paediatric Oncology (SIOP) Congress Show Palonosetron Is A Valuable Option For Treating Pediatric Patients Receiving Moderately To Highly Emetogenic Chemotherapy

October 23, 2014
·
7 min read